89 MD facilities bought drugs from company involved in meningitis outbreak
By By Andrea K. Walker
Oct 24, 2012 at 11:56 AM
The Food and Drug Administration released a new list of more than 3,000 hospitals that bought drugs from the company at the center of a nationwide fungal meningitis outbreak, including 89 facilities in Maryland.
The drugs bought by Maryland facilities from the New England Compounding facility include those other than the steroid that has been linked to the meningitis outbreak that has sickened 308 people and killed 23 in 17 states.
In Maryland 17 people have been sickened and 1 has died.
The new list includes regional hospital giant University of Maryland Medical Center, Mercy Medical Center, Saint Joseph Medical Center, Northwest Hospital and Katzen Eye Group, among others.
The FDA had released a list of medical facilities earlier this week, but took it down for accuracy reasons. The corrected list was released late Tuesday night. The regulatory agency said the list was taken from New England Compounding so it may not be complete.
The FDA said hospitals should throw out any medication bought from New England Compounding. Follow-up with patients should be done if the medicine was an injectable, was shipped on or after May 21 or was administered to patients on or after May 21.
Here is a list of the Maryland facilities:
ANNAPOLIS SURGERY CENTER, 2629 RIVA ROAD, SUITE 106, ANNAPOLIS MD, 21401
ANNE ARUNDEL MEDICAL CENTER, 2001 MEDICAL PARKWAY, ANNAPOLIS MD, 21401
ATLANTIC GENERAL HOSPITAL, 9733 HEALTHWAY DRIVE, BERLIN MD, 21811